Literature DB >> 11291556

Herceptin: from the bench to the clinic.

R Colomer1, L A Shamon, M S Tsai, R Lupu.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11291556     DOI： 10.1081/cnv-100000074

Source DB:  PubMed          Journal:  Cancer Invest        ISSN： 0735-7907            Impact factor:   2.176


× No keyword cloud information.
  6 in total

Review 1.  Peptide vaccines and targeting HER and VEGF proteins may offer a potentially new paradigm in cancer immunotherapy.

Authors:  Pravin T P Kaumaya; Kevin Chu Foy
Journal:  Future Oncol       Date:  2012-08       Impact factor: 3.404

Review 2.  Functional proteomics of breast cancer for signal pathway profiling and target discovery.

Authors:  Hubert Hondermarck; Laurent Dollé; Ikram El Yazidi-Belkoura; Anne-Sophie Vercoutter-Edouart; Eric Adriaenssens; Jérôme Lemoine
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-10       Impact factor: 2.673

3.  Immunotherapy for osteosarcoma: genetic modification of T cells overcomes low levels of tumor antigen expression.

Authors:  Nabil Ahmed; Vita S Salsman; Eric Yvon; Chrystal U Louis; Laszlo Perlaky; Winfried S Wels; Meghan K Dishop; Eugenie E Kleinerman; Martin Pule; Cliona M Rooney; Helen E Heslop; Stephen Gottschalk
Journal:  Mol Ther       Date:  2009-06-16       Impact factor: 11.454

4.  Modification of HER2 pre-mRNA alternative splicing and its effects on breast cancer cells.

Authors:  Jing Wan; Peter Sazani; Ryszard Kole
Journal:  Int J Cancer       Date:  2009-02-15       Impact factor: 7.396

5.  Use of translational modeling and simulation for quantitative comparison of PF-06804103, a new generation HER2 ADC, with Trastuzumab-DM1.

Authors:  Alison Betts; Tracey Clark; Paul Jasper; John Tolsma; Piet H van der Graaf; Edmund I Graziani; Edward Rosfjord; Matthew Sung; Dangshe Ma; Frank Barletta
Journal:  J Pharmacokinet Pharmacodyn       Date:  2020-07-24       Impact factor: 2.745

6.  Prognostic significance of EGFR and Her-2 in oral cavity cancer in betel quid prevalent area cancer prognosis.

Authors:  I-H Chen; J T Chang; C-T Liao; H-M Wang; L-L Hsieh; A-J Cheng
Journal:  Br J Cancer       Date:  2003-08-18       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.